Drug Pipeline

Elebsiran Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07128550 A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not… Viral Hepatitis Recruiting
NCT06903338 A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection Viral Hepatitis Active, Not Recruiting
Phase 2
NCT07142811 A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection Viral Hepatitis Active, Not Recruiting
Sponsors Running Elebsiran Trials
Vir Biotechnology, Inc. (3)
Get alerts when Elebsiran trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free